COVID Treatment & Management
Sort by:
California Medical Association
Epidemiology Update for California
FEATURING
Erica Pan
- 2 views
- September 25, 2023
This Week in Virology (TWiV)
Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines, Genome-Wide Association Study of Susceptibility to RSV Hospitalization in Young Children <5 Years of Age, and Safety and Immunogenicity of XBB.1.5-containing mRNA Vaccines
FEATURING
Daniel Griffin,
Vincent Racaniello
- 8 views
- September 25, 2023
This Week in Virology (TWiV)
Molnupiravir-Associated Mutational Signature in Global SARS-CoV-2 Genomes, Inhaled Fluticasone Furoate for Outpatient Treatment of COVID-19, and Autonomic Dysregulation in Long-Term Patients Suffering from Post-COVID-19 Syndrome
FEATURING
Daniel Griffin,
Vincent Racaniello
- 6 views
- October 5, 2023
Danyu Lin
Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections
- 183 views
- October 6, 2023
This Week in Virology (TWiV)
Molnupiravir for Intra-Household Prevention of COVID-19, FDA Authorization of Updated Novavax COVID-19 Vaccine, and SARS-CoV-2 Infection Triggers Pro-Atherogenic Inflammatory Responses in Human Coronary Vessels
FEATURING
Daniel Griffin,
Vincent Racaniello
- 18 views
- October 9, 2023
This Week in Virology (TWiV)
Disease Severity of RSV Compared with COVID-19 and Influenza Among Hospitalized Adults, Assessment of the Available Therapeutic Approaches for Severe COVID-19, and the Safety Profile of Nirmatrelvir/Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and COVID-19
FEATURING
Daniel Griffin,
Vincent Racaniello
- 15 views
- October 16, 2023
This Week in Virology (TWiV)
High Influenza Incidence and Disease Severity Among Children and Adolescents Aged <18 Years, Serotonin Reduction in Post-Acute Sequelae of Viral Infection, and Antiviral Efficacy of Molnupiravir Vs Ritonavir-Boosted Nirmatrelvir in Patients With Early Symptomatic COVID-19
FEATURING
Daniel Griffin,
Vincent Racaniello
- 12 views
- October 25, 2023
This Week in Virology (TWiV)
Mpox Neutralizing Antibodies at 6 Months from Mpox Infection or MVA-BN Vaccination, Nirmatrelvir and Molnupiravir and Post-COVID-19 Condition in Older Patients, and Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination
FEATURING
Daniel Griffin,
Vincent Racaniello
- 8 views
- November 1, 2023
This Week in Virology (TWiV)
Mpox Neutralizing Antibodies at 6 Months from Mpox Infection or MVA-BN Vaccination, Nirmatrelvir/Ritonavir Use in Pregnant Women with SARS-CoV-2, and Favorable Experience of Transplant Strategy Including Liver Grafts from COVID-19 Donors
FEATURING
Daniel Griffin,
Vincent Racaniello
- 10 views
- November 6, 2023
MedCram
Interferon's Role in SARS-CoV2 Infection and the Role of Hydrotherapy
FEATURING
Roger Seheult
- 5 views
- November 14, 2023
Cleveland Clinic Rheumatology
The Epidemic Long COVID-19: Questions & Implications for Rheumatology
FEATURING
Leonard Calabrese
- 21 views
- November 15, 2023